Table 2.
XG-20 | XG-19 | |||
---|---|---|---|---|
% Annexin V | P value (N = 5) | % Annexin V | P value (N = 5) | |
No cytokine | 48 ± 9 | 90 ± 3 | ||
IL-6 | 21 ± 7 | .008 (compared to No cytokine) | 56 ± 4 | .0003 (compared to No cytokine) |
Osteoclasts | 16 ± 3 | .01 (compared to No cytokine) | 41 ± 9 | .01 (compared to No cytokine) |
Osteoclasts + B-E8 | 25 ± 2 | .01 (compared to Osteoclasts) | 51 ± 8 | .05 (compared to Osteoclasts) |
Osteoclasts + TACI-Fc | 29 ± 5 | .02 (compared to Osteoclasts) | 67 ± 8 | .01 (compared to Osteoclasts) |
Osteoclasts + anti-IGF1R | 84 ± 8 | .0005 (compared to Osteoclasts) | 76 ± 9 | .003 (compared to Osteoclasts) |
Osteoclasts + anti-IL-10 | 18 ± 2 | NS (compared to Osteoclasts) | 42 ± 4 | NS (compared to Osteoclasts) |
Osteoclasts + anti-CCR2 | 19 ± 2 | NS (compared to Osteoclasts) | 43 ± 3 | NS (compared to Osteoclasts) |
NS: not significantly different